In situ characterization of stem cells-like biomarkers in meningiomas

In situ characterization of stem cells-like biomarkers in meningiomas

Abstract Background Meningioma cancer stem cells (MCSCs) contribute to tumor aggressiveness and drug resistance. Successful therapies developed for inoperable, recurrent, or metastatic tumors must target these cells and restrict their contribution to tumor progression. Unfortunately, the identity of...

Full description

Bibliographic Details
Main Authors: Hanin Alamir, Mona Alomari, Abdulla Ahmed A. Salwati, Mohamad Saka, Mohammed Bangash, Saleh Baeesa, Fahad Alghamdi, Angel Carracedo, Hans-Juergen Schulten, Adeel Chaudhary, Adel Abuzenadah, Deema Hussein
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Cancer Cell International
Subjects:
Meningioma
Cancer stem cells
Immunofluorescence
CD133
SOX2
Nestin
Online Access:http://link.springer.com/article/10.1186/s12935-018-0571-6

Internet

http://link.springer.com/article/10.1186/s12935-018-0571-6

Similar Items